← Portal hypertension & cirrhosis
Papers in Portal hypertension & cirrhosis
Page 3 · newest first
- Noninvasive diagnosis of liver fibrosis in schistosomiasis japonica: Opportunities and challengesPortal hypertension & cirrhosis · 2023
- Antibiotic prophylaxis in cirrhosis patients with upper gastrointestinal bleeding: An updated systematic review and meta‐analysisPortal hypertension & cirrhosis · 2022
- Nonalcoholic fatty liver disease (NAFLD) among older adultsPortal hypertension & cirrhosis · 2022
- Urinary neutrophil gelatinase‐associated lipocalin: A novel biomarker for predicting chronic kidney disease in patients with nonalcoholic fatty liver diseasePortal hypertension & cirrhosis · 2022
- Liver cirrhosis in Japan: Future global trends in the era of progressive antiviral therapyPortal hypertension & cirrhosis · 2022
- Comparison of survival prediction values of different scoring models for patients undergoing transjugular intrahepatic portal shunt: A multicenter retrospective studyPortal hypertension & cirrhosis · 2022
- Transforming one organ into another to overcome challenges in tissue engineeringPortal hypertension & cirrhosis · 2022
- A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placementPortal hypertension & cirrhosis · 2022
- Simultaneous splenectomy improving the outcomes of patients with hepatocellular carcinoma, cirrhosis and portal hypertension treated with hepatectomyPortal hypertension & cirrhosis · 2022
- Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemiaPortal hypertension & cirrhosis · 2022
- Non‐hemodynamic effects: Repurposing of nonselective beta‐blockers in cirrhosis?Portal hypertension & cirrhosis · 2022
- Management of non‐cirrhotic extrahepatic portal vein obstruction‐related portal hypertension in adult patientsPortal hypertension & cirrhosis · 2022
- The launch of Portal Hypertension & Cirrhosis in discovery and patient carePortal hypertension & cirrhosis · 2022
- Trained innate immunity and human adenovirus infection as a novel mechanism linked to the severe acute hepatitis of unknown origin in children during the COVID‐19 pandemicPortal hypertension & cirrhosis · 2022
- T cells and liver fibrosisSHILAP Revista de lepidopterología · 2022
- Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectivesPortal hypertension & cirrhosis · 2022
- MRI in liver cirrhosisPortal hypertension & cirrhosis · 2022
- Endothelins and liver cirrhosisPortal hypertension & cirrhosis · 2022
- Impact of endoscopic ultrasound examination for deep esophageal collateral veins evaluation in liver cirrhosis patients prior to endoscopic treatment: A case seriesPortal hypertension & cirrhosis · 2022
- Nonselective beta‐blockers reduce mortality in patients with acute‐on‐chronic liver failurePortal hypertension & cirrhosis · 2022
- Hepatic venous pressure gradient (HVPG) measurement: Tips and pitfalls of hepatic venous catheterizationPortal hypertension & cirrhosis · 2022
- Thirty years' transjugular intrahepatic portosystemic stent‐shunt (TIPS) in China: Opportunities and challengesPortal hypertension & cirrhosis · 2022
- Tolerance and acceptance of hepatic venous pressure gradient measurement in cirrhosis (CHESS1904): An international multicenter studyPortal hypertension & cirrhosis · 2022
- Sarcopenic obesity in liver disease: Handling both sides of the pennyPortal hypertension & cirrhosis · 2022